To support the important work happening in academic research labs around the world, we continue to offer complimentary human induced pluripotent stem cell (hiPSC) lines (processing and shipping not included) to academic researchers. Details below ⬇️

Todd Herron, Director of our hiPSC BioBank at Greenstone, will be a co-chair for the session “From Bench to Benefit-Cardiac NAMs for Predictive Safety and Efficacy Assessment” on September 23rd at the SPS 2026 Annual Meeting in Montreal. Read more: linkedin.com/posts/greenston…

Greenstone Biosciences has been awarded a Breakthrough T1D Industry Discovery and Development Partnership grant to develop a patient-derived islet cell platform for type 1 diabetes research. Read the full press release here: biopharmadive.com/press-rele…

In a new article from Drug Target Review, Greenstone Biosciences co-founder Dr. @Joseph_C_Wu discusses how New Approach Methodologies (NAMs) can help close the gap between existing models and human relevance. Read the full article here: drugtargetreview.com/home/re…

Greenstone Biosciences has been awarded a Catalyze R61 grant from the National Heart, Lung, and Blood Institute (NHLBI), part of NIH, to develop new therapeutic approaches for cardiac fibrosis and dilated cardiomyopathy in DMD Reade more here: linkedin.com/posts/greenston…

This week, the U.S. House of Representatives passed the FDA Modernization Act 3.0, an important step in advancing the usage of New Approach Methodologies (NAMs) such as organoids, organ-on-chip systems, and computational models. Read more here: linkedin.com/company/8056307…

We are just three weeks out from the next installment of our Greenstone Biosciences webinar series, featuring Dr. Passley Hargrove-Grimes, Program Officer at the National Institutes of Health. Sign up today: us06web.zoom.us/webinar/regi…

Greenstone Biosciences co-founder Dr. @Joseph_C_Wu will be featured in the upcoming documentary “The New Gold Standard,” which explores the science replacing animal testing. Watch the trailer here: youtu.be/NkA6HeAzSxs Learn more about Greenstone: greenstonebio.com

BAG3-associated cardiomyopathy can progress rapidly, but the biology remains difficult to study in conventional models. To help this research, Greenstone Biosciences is now offering 10 patient-derived iPSC lines carrying distinct BAG3 variants Read more: linkedin.com/posts/greenston…

PTEN Hamartoma Tumor Syndrome is a rare inherited condition caused by changes in the PTEN gene, and Greenstone Biosciences has contributed to a new paper published in Stem Cell Research that expands tools available to researchers studying it Read more: linkedin.com/feed/update/urn…

The @FDA's push to reduce reliance on animal testing is a call to action for platforms built to replace it. Greenstone Biosciences’ iPSC biobank includes more than 2,500 patient-derived lines of diverse ancestries, ages, and diseases. Read more here: linkedin.com/feed/update/urn…

On June 22, HHS unveiled Operation TrialBlazer, an initiative to accelerate clinical research across the pipeline, from IND submission through late-stage pivotal trials, with a focus on NAMs. Read more how how these changes will shape the industry here: linkedin.com/feed/update/urn…

Join tomorrow on Tuesday, June 23rd at 10 AM PST / 1 PM EST for the next installment of Greenstone Bioscience's webinar series, featuring Dr. Weida Tong, Director at the National Center for Toxicological Research (NCTR/FDA). Sign up here: us06web.zoom.us/webinar/regi…

Join next week on Tuesday, June 23rd at 10 AM PST / 1 PM EST for the next installment of Greenstone Bioscience's webinar series, featuring Dr. Weida Tong, Director at the National Center for Toxicological Research (NCTR/FDA). Sign up here: us06web.zoom.us/webinar/regi…

Join us on Tuesday, June 23rd at 10 AM PST / 1 PM EST for the next installment of Greenstone Bioscience's webinar series, featuring Weida Tong, Director at the National Center for Toxicological Research (NCTR/FDA). Sign up here: us06web.zoom.us/webinar/regi…

Join us on Tuesday, June 23rd at 10 AM PST / 1 PM EST for the next installment of Greenstone Bioscience's webinar series, featuring Weida Tong, Director at the National Center for Toxicological Research (NCTR/FDA). Sign up here: us06web.zoom.us/webinar/regi…

Greenstone Biosciences is exhibiting at the MPS World Summit 2026, taking place up until May 29th at the Walter E. Washington Convention Center in Washington DC. Find us at Booth #602 to learn about our human iPSC-derived models. Learn more here: mpsworldsummit.org/

Greenstone Biosciences will be exhibiting at the MPS World Summit 2026, taking place on May 26-29th at the Walter E. Washington Convention Center in Washington DC. Find us at Booth #602 to learn about our human iPSC-derived models. Learn More here: mpsworldsummit.org/

Recent research from Greenstone Biosciences Biobank Director Todd Herron, conducted during his time at the University of Michigan, sheds light on the arrhythmogenic mechanisms underlying Fabry disease Read the paper here: frontiersin.org/journals/car…

If you missed it live, the newest Greenstone Biosciences Webinar featuring Roger Kamm, Cecil and Ida Green Distinguished Professor of Biological and Mechanical Engineering at MIT is now available to watch online! Watch it here: youtube.com/watch?v=G8SClf_K…

We are now just one day out from the next installment of our Greenstone Biosciences webinar series, featuring Roger D. Kamm of the @kamm_lab, Cecil and Ida Green Distinguished Professor of Biological and Mechanical Engineering at MIT. Sign up now: us06web.zoom.us/webinar/regi…